Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique.
about
Clinical experimentation with aerosol antibiotics: current and future methods of administration.Can lung deposition data act as a surrogate for the clinical response to inhaled asthma drugs?Inhaled and nasal corticosteroids: safety aspects.Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.Methods to identify drug deposition in the lungs following inhalationThe relationship between prescribed and delivered doses of inhaled corticosteroids in adult asthmatics.Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.Study of Proper use of Inhalational Devices by Bronchial Asthma or COPD Patients Attending a Tertiary Care HospitalWheeze in childhood: is the spacer good enough?Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients.Scientific respiratory symposium, paris june 2010Aerosol therapy for obstructive lung diseases: device selection and practice management issues.Pulmonary drug delivery. Part II: the role of inhalant delivery devices and drug formulations in therapeutic effectiveness of aerosolized medicationsClinical efficacy of inhaler devices containing beta(2)-agonist bronchodilators in the treatment of asthma: cochrane systematic review and meta-analysis of more than 100 randomized, controlled trials.Plume Characteristics of Two HFA-Driven Inhaled Corticosteroid/Long-Acting Beta2-Agonist Combination Pressurized Metered-Dose Inhalers.How to match the optimal currently available inhaler device to an individual child with asthma or recurrent wheeze.Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstructionUrinary pharmacokinetic methodology to determine the relative lung bioavailability of inhaled beclometasone dipropionate.Aerosol delivery systems for bronchial asthmaPulmonary vaccine delivery.The rejuvenated pressurised metered dose inhaler.New treatment options in allergic rhinitis: patient considerations and the role of ciclesonideUse of Respimat Soft Mist inhaler in COPD patientsThe challenge of delivering therapeutic aerosols to asthma patientsAre Sudanese community pharmacists capable to prescribe and demonstrate asthma inhaler devices to patrons? A mystery patient studyCustomizing inhaled therapy to meet the needs of COPD patients.Guidelines for aerosol devices in infants, children and adults: which to choose, why and how to achieve effective aerosol therapy.Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma.The role of nebulized therapy in the management of COPD: evidence and recommendations.Inhaled chemotherapy in lung cancer: future concept of nanomedicine.Use of breath-actuated inhalers in patients with asthma and COPD - an advance in inhalational therapy: a systematic review.Advances in metered dose inhaler technology: hardware development.Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery.Optimising Inhaled Pharmacotherapy for Elderly Patients with Chronic Obstructive Pulmonary Disease: The Importance of Delivery Devices.Inhalation devices: from basic science to practical use, innovative vs generic products.A systematic review of instruments aimed at evaluating metered-dose inhaler administration technique in children.Scientific Rationale for Determining the Bioequivalence of Inhaled Drugs.Routine Use of Budesonide/Formoterol Fixed Dose Combination in Elderly Asthmatic Patients: Practical Considerations.Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.Effect of AeroChamber Plus™ on the lung and systemic bioavailability of beclometasone dipropionate/formoterol pMDI.
P2860
Q30448377-001E0095-C36D-4EA6-A00A-36C910E48703Q30597431-15CBC28B-CAF7-48AF-BCC0-BD54873B8B7DQ33851527-A284E6E6-E4A2-4D48-8DF0-F9A5593C0F0BQ33976334-A5148F38-5826-4786-80A9-5D1987514F8AQ34229278-78A77DD6-0AC2-4D91-A189-36486C5D1494Q34471924-3A33B96B-F0A6-4AD8-B875-36625832475BQ34605346-19117C39-FB3E-4315-AF7B-7C3AA61F5E25Q34618115-03591450-8B3B-4FE6-98D1-C86F7D30A4CAQ34952951-844E53CE-2A1C-4411-8AEB-689A165EAD48Q35070070-C1220571-E5B4-490E-92D9-2133803EB754Q35117833-16CA709C-3E11-464F-8C50-A728EF81FFAFQ35484494-C00A9556-F664-4DB3-AFE2-4BE06BA6DA90Q35583186-8067535F-E1E4-4EE4-849B-03B048E1DC8EQ35627671-592AA833-339D-476F-81A0-A29F18E9633AQ35671319-2CA773AC-0E92-436C-9379-6CA3556E8F4BQ35939339-2C8C8D4E-AFE5-4A7C-B716-7E06A27E421FQ36280545-3D2AC34F-73E3-4DE4-9114-5EF5F71A7FD7Q36336028-5FAA4C54-0D61-4EE1-8124-EEA5BDEB77FCQ36680598-B6512011-1155-4DC9-8377-A22288B60A1BQ36780141-2A632EF9-6720-4E24-8287-A0AD814B1B63Q36815920-6275182D-105F-4BC6-B7C7-6954A3333659Q36823610-6759745D-6377-4EA6-856F-06733696C96CQ37018826-C8FE665E-83EF-48BF-BC39-DA47985D1AC7Q37105708-4D363BD2-36F5-437F-BF0A-3A84F471CA66Q37190875-D8451903-2B6C-4A61-B804-FAF83855620BQ37702735-2FADC754-88BD-4B2B-949B-6558FF626FA5Q37920900-962E5A23-06A3-49E1-9401-C851656AB5A3Q37979251-7C02DE9B-FA42-4047-9237-FB0136622D0DQ37980189-F10E8309-50E5-4686-BE7A-D52EB2477FADQ38012447-764D28BA-6658-46B7-B7E4-3F11912AE4CAQ38170181-9C2FCB94-1164-4738-B5CA-29884F17B073Q38172855-6E20914B-2C02-41A0-B477-79FF462E280CQ38175421-D5EB293A-7BB7-4F3E-8F72-AAB4CDC10A59Q38842452-E2228DCB-AE33-45BC-B46C-C1836DC97730Q38856654-D088AC40-227F-4AD1-B0A6-A1F8311B4BA4Q38865801-65B0A5A1-583E-4C77-9EBF-BA4E075F2CEDQ38909886-3FCAB1EE-2CC8-43CE-8BF9-38E08407365AQ38930261-6DED1E16-FFA5-4DEA-AB6B-C6E0614E8078Q38981185-62F181B3-924C-4702-A394-ECEBF6B7F24FQ39962294-EEB5CCB7-18A7-46C7-B466-A42354A9C1D7
P2860
Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Improvement of drug delivery w ...... s with poor inhaler technique.
@ast
Improvement of drug delivery w ...... s with poor inhaler technique.
@en
type
label
Improvement of drug delivery w ...... s with poor inhaler technique.
@ast
Improvement of drug delivery w ...... s with poor inhaler technique.
@en
prefLabel
Improvement of drug delivery w ...... s with poor inhaler technique.
@ast
Improvement of drug delivery w ...... s with poor inhaler technique.
@en
P2093
P2860
P356
P1433
P1476
Improvement of drug delivery w ...... s with poor inhaler technique.
@en
P2093
P2860
P304
P356
10.1136/THX.46.10.712
P407
P577
1991-10-01T00:00:00Z